I feel they really need to get the RX7 & 9 approved and into manufacturing in order to provide some sort of revenue stream otherwise we will be heading down the cap raising path once again. While the MDMA stuff is good I can’t see it having a major impact to the share price in the short term in my opinion. Hope I’m proven wrong.
- Forums
- ASX - By Stock
- EMD
- Ann: Empax Centre Selected As Key Site In Global PTSD Study
Ann: Empax Centre Selected As Key Site In Global PTSD Study, page-14
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
5.0¢ |
Change
0.014(38.9%) |
Mkt cap ! $19.22M |
Open | High | Low | Value | Volume |
3.8¢ | 5.0¢ | 3.8¢ | $101.0K | 2.192M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13250 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 55844 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13250 | 0.048 |
2 | 67792 | 0.047 |
1 | 400000 | 0.046 |
2 | 72222 | 0.045 |
1 | 150000 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 55844 | 3 |
0.052 | 875000 | 2 |
0.055 | 50000 | 1 |
0.059 | 160000 | 2 |
0.060 | 447801 | 5 |
Last trade - 14.22pm 05/09/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |